We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

It works by targeting parts of the brain that regulate appetite. Like liraglutide, semaglutide is FDA approved at a higher dose for the treatment of obesity and at a lower dose for the management ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

New Delhi: A study has found that brain chemicals such as dopamine and serotonin work together in controlling hunger and food ...

A new study reveals that modulating endocannabinoids in the brain can reduce food intake and boost physical activity, ...

Researchers at CRCHUM found that targeting the enzyme ABHD6 in specific brain regions of mice reduces obesity without causing ...

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated ...

GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...

Hidden Fat Predicts Alzheimer's 20 Years Ahead of Symptoms Dec. 2, 2024 — Researchers have linked a specific type of body fat to the abnormal proteins in the brain that are hallmarks of ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.